NF-κB, an Evolutionarily Conserved Mediator of Immune and Inflammatory Responses

  • Changchun Xiao
  • Sankar Ghosh
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 560)

Abstract

NF-κB is a family of structurally related and evolutionarily conserved transcription factors. There are five NF-κB proteins in mammals: RelAIp65, RelB, c-Rel, NF-κB1 (p50 and its precursor p105), and NF-κB2 (p52 and its precursor p100); and three in flies: Dorsal, Dif, and Relish. All NFκB proteins contain a N-terminal 300 amino acid re1 homology domain, which is responsible for DNA binding, dimerization, and interaction with the inhibitors of NF-κB, the IκB family proteins. RelA, RelB, c-Rel, Dorsal, and Dif have a transcription activation domain at their C-termini, where p100, p105, and Relish contain ankyrin repeats, signature structures of IκB proteins. NF-κB proteins form hetero- or homodimers and are retained in the cytoplasm by IκBs. There are five IκB proteins in mammals: IκBα, IκBβ, IκBγ, IκBε, and Bcl-3; and one IκB protein in fly: Cactus. 1κBα and IκBβ share a tripartite organization: an N-terminal domain that is phosphorylated in response to signals, a central ankyrin repeat domain, and a C-terminal PEST domain that is involved in the basal turnover of the protein. All other IκB proteins have central ankyrin repeat domain, but differ from IκBα and IκBβ at their N- and C- terminal domains. IκB proteins form complexes with NF-κB dimers, with ankyrin repeats in direct contact with re1 homology domains. This interaction is essential to keep NF-κB dimers in the cytoplasm, thus physically sequestrating them from their transcriptional target.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ghosh, S., May, M. J., & Kopp, E. B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16, 225–60 (1998).PubMedCrossRefGoogle Scholar
  2. 2.
    Ghosh, S. & Karin, M. Missing pieccs in the NFkB puzzle. Cell 109, S81–S96 (2002).PubMedCrossRefGoogle Scholar
  3. 3.
    Aderem, A. & Ulevitch, R. J. Toll-like receptors in the induction of the innate immune response. Nature 406, 782–7. (2000).PubMedCrossRefGoogle Scholar
  4. 4.
    Hoffmann, J. A. & Reichhart, J. M. Drosophila innate immunity: an evolutionary perspective. Nat Immunol 3, 121–6. (2002).PubMedCrossRefGoogle Scholar
  5. 5.
    Akira, S., Takeda, K. & Kaisho, T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2, 675–80. (2001).PubMedCrossRefGoogle Scholar
  6. 6.
    Kopp, E. et al. ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway. Genes Dev 13, 2059–71. (1999).PubMedGoogle Scholar
  7. 7.
    Deng, L. et al. Activation of the Ikappaß kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex und a unique polyubiquitin chain (2000).Google Scholar
  8. 8.
    Wang, C. et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346–51. (2001).PubMedCrossRefGoogle Scholar
  9. 9.
    Sanjo, H. et al. TAB2 is essential for prevention of apoptosis in fetal liver but not for interleukin-1 signaling. Mol Cell Biol 23, 1231–8. (2003).PubMedCrossRefGoogle Scholar
  10. 10.
    Komatsu, Y. et al. Targeted disruption of the Tab1 gene causes embryonic lethality and defects in cardiovascular and lung morphogenesis. Mech Dev 119, 239–249 (2002).PubMedCrossRefGoogle Scholar
  11. 11.
    Mishina, Y., Suzuki, A., Ueno, N. & Behringer, R. R. Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev 9, 3027–37. (1995).PubMedGoogle Scholar
  12. 12.
    Shi, Y. & Massague, J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113, 685–700. (2003).PubMedCrossRefGoogle Scholar
  13. 13.
    Huang, J. D., Schwyter, D. H., Shirokawa, J. M. & Courey, A. J. The interplay between multiple enhancer and silencer elements defines the pattern of decapentaplegic expression. Genes Dev 7, 694–704. (1993).PubMedGoogle Scholar
  14. 14.
    Wharton, K. A., Ray, R. P. & Gelbart, W. M. An activity gradient of decapentaplegic is necessary for the specification of dorsal pattern elements in the Drosophila embryo. Development 117, 807–22. (1993).PubMedGoogle Scholar
  15. 15.
    Letterio, J. J. & Roberts, A. B. TGF-beta: a critical modulator of immune cell function. Clin Immunol Immunopathol 84, 244–50. (1997).PubMedCrossRefGoogle Scholar
  16. 16.
    Geiser, A. G. et al. Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype. Proc Natl Acad Sci U S A 90, 9944–8. (1993).PubMedCrossRefGoogle Scholar
  17. 17.
    Vodovotz, Y. et al. Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor beta 1 null mouse. J Exp Med 183, 2337–42. (1996).PubMedCrossRefGoogle Scholar
  18. 18.
    Bitzer, M. et al. A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA. Genes Dev 14, 187–97. (2000).PubMedGoogle Scholar
  19. 19.
    Xiao, C., Shim, J-H., Kluppel, M., Zhang, S-M., Dong, C., Flavell, R. A., Fu, X-Y., Wrana, J. L., Hogan, B. L. M., and Ghosh, S. Ecsit is required for Bmp signaling and mesoderm formation during mouse embryogenesis. Genes Dev 17 2933–2949 (2003).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • Changchun Xiao
    • 1
  • Sankar Ghosh
    • 1
  1. 1.Section of Immunobiology, Department of Molecular Biophysics and BiochemistryYale University School of MedicineNew Haven

Personalised recommendations